BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27121875)

  • 1. Genetic susceptibility to the endemic form of NPC.
    Bei JX; Zuo XY; Liu WS; Guo YM; Zeng YX
    Chin Clin Oncol; 2016 Apr; 5(2):15. PubMed ID: 27121875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
    Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
    Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
    EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histocompatibility locus antigens regions contribute to the ethnicity bias of Epstein-Barr virus-associated nasopharyngeal carcinoma in higher-incidence populations.
    Roy Chattopadhyay N; Chakrabarti S; Chatterjee K; Deb Roy S; Kumar Sahu S; Reddy RR; Das P; Bijay Kanrar B; Kumar Das A; Tsering S; Puii Z; Zomawia E; Singh YI; Suryawanshi A; Choudhuri T
    Scand J Immunol; 2019 Oct; 90(4):e12796. PubMed ID: 31145476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
    BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
    Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
    Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches.
    Lo KW; Chung GT; To KF
    Semin Cancer Biol; 2012 Apr; 22(2):79-86. PubMed ID: 22245473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidome-wide association analysis of Epstein-Barr virus identifies epitope repertoires associated with nasopharyngeal carcinoma.
    Deng CM; Wang TM; He YQ; Zhang WL; Xue WQ; Li DH; Yang DW; Wang QL; Liao Y; Diao H; Jiang CT; Zhang JB; Yuan LL; Chen XY; Zhou T; Li XZ; Zhang PF; Zheng XH; Zhang SD; Hu YZ; Xu M; Zeng MS; Feng L; Jia WH
    J Med Virol; 2023 Jun; 95(6):e28860. PubMed ID: 37310118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma.
    Bei JX; Jia WH; Zeng YX
    Semin Cancer Biol; 2012 Apr; 22(2):96-106. PubMed ID: 22313875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection.
    Yang L; Liu B; Qiu F; Huang B; Li Y; Huang D; Yang R; Yang X; Deng J; Jiang Q; Zhou Y; Lu J
    Carcinogenesis; 2014 Jan; 35(1):46-52. PubMed ID: 24056810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
    Fung SY; Lam JW; Chan KC
    Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma.
    Xu M; Yao Y; Chen H; Zhang S; Cao SM; Zhang Z; Luo B; Liu Z; Li Z; Xiang T; He G; Feng QS; Chen LZ; Guo X; Jia WH; Chen MY; Zhang X; Xie SH; Peng R; Chang ET; Pedergnana V; Feng L; Bei JX; Xu RH; Zeng MS; Ye W; Adami HO; Lin X; Zhai W; Zeng YX; Liu J
    Nat Genet; 2019 Jul; 51(7):1131-1136. PubMed ID: 31209392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors.
    Hildesheim A; Wang CP
    Semin Cancer Biol; 2012 Apr; 22(2):107-16. PubMed ID: 22300735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
    Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
    Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.
    Ahmed N; Abusalah MAHA; Farzand A; Absar M; Yusof NY; Rabaan AA; AlSaihati H; Alshengeti A; Alwarthan S; Alsuwailem HS; Alrumaih ZA; Alsayyah A; Yean CY
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association between human leukocyte antigen and nasopharyngeal-carcinoma].
    Tang MZ; Cai YL; Zheng YM; Zeng Y
    Yi Chuan; 2012 Dec; 34(12):1505-12. PubMed ID: 23262096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association study of chromosome 4 STRs polymorphisms with nasopharyngeal carcinoma].
    Guo XC; O'Brien SJ; Winkler C; Scott K; Hutcheson H; David V; Kessing B; Zheng YM; Liao J; Lui Y; Guy de T; Zeng Y
    Yi Chuan; 2006 Jul; 28(7):783-90. PubMed ID: 16825163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.
    Coghill AE; Hsu WL; Yang Q; Wang CP; Lou PJ; Yu KJ; Yu G; Diehl SR; Chen CJ; Goldstein AM; Hildesheim A
    J Gen Virol; 2018 Sep; 99(9):1268-1273. PubMed ID: 29975184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.